AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32027157 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) protocols for anxiety disorders
Number of subjects: 223
Study 33637061 — intervention group
Group type: EXPERIMENTAL
Intervention: MOVE group treatment (MOVE-G)
Number of subjects: 300
Study 33637061 — intervention group
Group type: COMPARATOR
Intervention: MOVE individual treatment (MOVE-I)
Number of subjects: 300
Study 33637061 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (MOVE-G and MOVE-I)
Number of subjects: 300
Study 32069067 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulclock (Active group)
Number of subjects: 16
Study 32069067 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulclock (Overall population)
Number of subjects: 16
Study 36004426 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized carbohydrate-rich snack (198 kcal) consumed in the morning
Number of subjects: 24
Study 36004426 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized carbohydrate-rich snack (198 kcal) consumed in the evening
Number of subjects: 24
Study 36004426 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized carbohydrate-rich snack (198 kcal) consumed in the afternoon
Number of subjects: 24
Study 34049452 — intervention group
Group type: COMPARATOR
Intervention: Oral cannabis (10 mg THC)
Number of subjects: 20
Study 34049452 — intervention group
Group type: COMPARATOR
Intervention: Oral cannabis (25 mg THC)
Number of subjects: 20
Study 34049452 — intervention group
Group type: COMPARATOR
Intervention: Vaporized cannabis (5 mg THC)
Number of subjects: 20
Study 34049452 — intervention group
Group type: COMPARATOR
Intervention: Vaporized cannabis (20 mg THC)
Number of subjects: 20
Study 34049452 — intervention group
Group type: EXPERIMENTAL
Intervention: DRUID® test
Number of subjects: 20
Study 34049452 — intervention group
Group type: EXPERIMENTAL
Intervention: Field sobriety tests
Number of subjects: 20
Study 34049452 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood THC concentrations after ingestion
Number of subjects: 20
Study 34049452 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood THC concentrations after inhalation
Number of subjects: 20
Study 32016702 — intervention group
Group type: EXPERIMENTAL
Intervention: RESTORE intervention (individualized, physiotherapist-prescribed home program of weight-bearing balance and strength exercises, fall prevention advice)
Number of subjects: 336
Study 32016702 — intervention group
Group type: EXPERIMENTAL
Intervention: RESTORE intervention
Number of subjects: 336
Study 32016702 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 336
Study 35427708 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium monotherapy
Number of subjects: 31
Study 33982406 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 1% cyclopentolate hydrochloride
Number of subjects: 6
Study 33982406 — intervention group
Group type: COMPARATOR
Intervention: Topical 1% cyclopentolate hydrochloride combined with 2.5% phenylephrine
Number of subjects: 6
Study 35165471 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold flowable gutta‐percha
Number of subjects: 90
Study 32918397 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized self-report measure for assessing patient reactions to diagnoses
Number of subjects: 1271
Study 32918397 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia diagnosis
Number of subjects: 1271
Study 32918397 — intervention group
Group type: EXPERIMENTAL
Intervention: Anorexia nervosa diagnosis
Number of subjects: 1271
Study 33776997 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine 8 mg daily for 4 weeks
Number of subjects: 22
Study 33776997 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine treatment
Number of subjects: 22
Study 32212395 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention to prevent serious fall injuries
Number of subjects: 5451
Study 34766790 — intervention group
Group type: COMPARATOR
Intervention: Institutional care (care as usual)
Number of subjects: 271
Study 34766790 — intervention group
Group type: COMPARATOR
Intervention: Foster care
Number of subjects: 271
Study 34766790 — intervention group
Group type: COMPARATOR
Intervention: Never-institutionalized children
Number of subjects: 271
Study 34766790 — intervention group
Group type: EXPERIMENTAL
Intervention: Friendship quality (low quality)
Number of subjects: 271
Study 34766790 — intervention group
Group type: EXPERIMENTAL
Intervention: Friendship quality (high quality)
Number of subjects: 271
Study 34158524 — intervention group
Group type: EXPERIMENTAL
Intervention: Phrenic nerve block (PNB) with 2% lidocaine
Number of subjects: 0
Study 34158524 — intervention group
Group type: COMPARATOR
Intervention: Control group with saline
Number of subjects: 0
Study 614312649 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal volume of 1 mul fluorescein (mTBUT)
Number of subjects: 41
Study 614312649 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional fluorescein strip (TBUT)
Number of subjects: 41
Study 614312649 — intervention group
Group type: COMPARATOR
Intervention: Non-invasive method (NIBUT)
Number of subjects: 41
Study 33557497 — intervention group
Group type: EXPERIMENTAL
Intervention: iRoot BP Plus
Number of subjects: 20
Study 33557497 — intervention group
Group type: COMPARATOR
Intervention: MTA
Number of subjects: 20
Study 32892963 — intervention group
Group type: EXPERIMENTAL
Intervention: CHANGE program (nutrition and behavior management strategies)
Number of subjects: 10
Study 32892963 — intervention group
Group type: COMPARATOR
Intervention: Parent education program (ASD education)
Number of subjects: 10
Study 35929474 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI-plus (extensive ablation)
Number of subjects: 469
Study 35929474 — intervention group
Group type: COMPARATOR
Intervention: PVI-only (pulmonary vein isolation)
Number of subjects: 469
Study 616388376 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin-tazobactam + Tanreqing injection
Number of subjects: 64
Study 616388376 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin-tazobactam
Number of subjects: 64
Study 33724079 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined visceral adiposity (per 1 SD)
Number of subjects: 453702
Study 32277344 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-step infusion of imipenem (0.5 g q6h)
Number of subjects: 35
Study 32277344 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-step infusion of imipenem (1.0 g q8h)
Number of subjects: 35
Study 32277344 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended infusion of imipenem (0.5 g q6h)
Number of subjects: 35
Study 32277344 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended infusion of imipenem (1.0 g q8h)
Number of subjects: 35
Study 33413049 — intervention group
Group type: EXPERIMENTAL
Intervention: AMCAFF (caffeine 3 mg/kg in the morning)
Number of subjects: 11
Study 33413049 — intervention group
Group type: COMPARATOR
Intervention: PMPLAC (placebo in the evening)
Number of subjects: 11
Study 33413049 — intervention group
Group type: COMPARATOR
Intervention: AMPLAC (placebo in the morning)
Number of subjects: 11
Study 33531012 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm bath
Number of subjects: 12
Study 33531012 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrared radiation
Number of subjects: 12
Study 35395548 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline 2 mg/day
Number of subjects: 25
Study 35395548 — intervention group
Group type: COMPARATOR
Intervention: Varenicline 1 mg/day
Number of subjects: 25
Study 35395548 — intervention group
Group type: COMPARATOR
Intervention: Varenicline 0 mg/day (placebo)
Number of subjects: 25
Study 32900336 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate therapy (continuous infusion)
Number of subjects: 118
Study 32900336 — intervention group
Group type: COMPARATOR
Intervention: Placebo (compound sodium lactate)
Number of subjects: 118
Study 32900336 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring with arterial blood gas analysis
Number of subjects: 118
Study 32900336 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of therapy until target pH is achieved
Number of subjects: 118
Study 32900336 — intervention group
Group type: EXPERIMENTAL
Intervention: Target pH
Number of subjects: 118
Study 32911350 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 179
Study 32005465 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional group (manual PAR scoring using study models)
Number of subjects: 67
Study 32005465 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect digital group (automated PAR scoring using scanned study models)
Number of subjects: 67
Study 32005465 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct digital group (automated PAR scoring using intraoral scans)
Number of subjects: 67
Study 32005465 — intervention group
Group type: COMPARATOR
Intervention: Intraoral scanning
Number of subjects: 67
Study 32005465 — intervention group
Group type: COMPARATOR
Intervention: Impression-taking
Number of subjects: 67
Study 34267156 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% hypertonic saline (HTS) (2 mL/kg)
Number of subjects: 51
Study 34267156 — intervention group
Group type: COMPARATOR
Intervention: 20% mannitol (4.6 mL/kg)
Number of subjects: 51
Study 34267156 — intervention group
Group type: EXPERIMENTAL
Intervention: Both 7.5% HTS and 20% mannitol
Number of subjects: 51
Study 33860721 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg hydrocortisone
Number of subjects: 104
Study 33860721 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg yohimbine
Number of subjects: 104
Study 33860721 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg hydrocortisone/10 mg yohimbine combined
Number of subjects: 104
Study 33860721 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 35348015 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant formula with specific prebiotics and postbiotics
Number of subjects: 100
Study 35348015 — intervention group
Group type: COMPARATOR
Intervention: Standard infant formula
Number of subjects: 100
Study 35348015 — intervention group
Group type: COMPARATOR
Intervention: Breast-fed infants
Number of subjects: 100
Study 34719711 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care screening tool administered daily for 8 weeks
Number of subjects: 17
Study 32506733 — intervention group
Group type: EXPERIMENTAL
Intervention: TN + MB/PDT
Number of subjects: 20
Study 32506733 — intervention group
Group type: EXPERIMENTAL
Intervention: TN + MAL/PDT
Number of subjects: 20
Study 33811649 — intervention group
Group type: EXPERIMENTAL
Intervention: Group counseling based on the solution-focused approach (SFA)
Number of subjects: 31
Study 33248239 — intervention group
Group type: EXPERIMENTAL
Intervention: Antebrachial access
Number of subjects: 410
Study 33248239 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachial access
Number of subjects: 410
Study 33248239 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients overall
Number of subjects: 410
Study 33248239 — intervention group
Group type: COMPARATOR
Intervention: Nondiabetic patients overall
Number of subjects: 410
Study 33493652 — intervention group
Group type: EXPERIMENTAL
Intervention: Philosophy for children (P4C) intervention
Number of subjects: 37
Study 33493652 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based interventions (MBI)
Number of subjects: 37
Study 32036983 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% Eucalyptus leaves (EL) supplementation
Number of subjects: 180
Study 32036983 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% Eucalyptus leaves (EL) supplementation
Number of subjects: 180
Study 32036983 — intervention group
Group type: COMPARATOR
Intervention: Control (0% Eucalyptus leaves)
Number of subjects: 180
Study 33962675 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurocognitive Empowerment for Addiction Treatment (NEAT)
Number of subjects: 80
Study 33962675 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 80
Study 33313729 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Number of subjects: 0
Study 33313729 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 0
Study 32741505 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Cognitive Behavioral Treatment (I-CBT)
Number of subjects: 111
Study 32741505 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 111
Study 35579016 — intervention group
Group type: EXPERIMENTAL
Intervention: MBH + EPO
Number of subjects: 42
Study 35579016 — intervention group
Group type: COMPARATOR
Intervention: MBH alone
Number of subjects: 42
Study 35579016 — intervention group
Group type: EXPERIMENTAL
Intervention: EPO usage
Number of subjects: 42
Study 33475138 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin + insulin (SITA)
Number of subjects: 51
Study 33475138 — intervention group
Group type: COMPARATOR
Intervention: Insulin alone (CONT)
Number of subjects: 51
Study 32227157 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic perconditioning (4 cycles of 5-minute inflations and 5-minute deflations to the thigh to 110 mm Hg above systolic blood pressure) in addition to standard care
Number of subjects: 188
Study 32227157 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 188
Study 32227157 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic perconditioning (in addition to standard care)
Number of subjects: 188
Study 33383266 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus anterior plane block (SAPB)
Number of subjects: 60
Study 32428718 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep-promoting intervention with eye patches and earplugs
Number of subjects: 41
Study 32428718 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 41
Study 32428718 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 41
Study 34244327 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious injuries reported by participants
Number of subjects: 662
Study 34244327 — intervention group
Group type: EXPERIMENTAL
Intervention: Common injuries reported
Number of subjects: 662
Study 34244327 — intervention group
Group type: EXPERIMENTAL
Intervention: Injury occurrence related to activities
Number of subjects: 662
Study 34244327 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimated treatment cost per injury
Number of subjects: 662
Study 34244327 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious injuries over time
Number of subjects: 662
Study 33591329 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal mesh hysteropexy
Number of subjects: 0
Study 33591329 — intervention group
Group type: COMPARATOR
Intervention: Vaginal hysterectomy with uterosacral ligament suspension
Number of subjects: 0
Study 35621217 — intervention group
Group type: EXPERIMENTAL
Intervention: Broad digital intervention
Number of subjects: 600
Study 35621217 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused digital intervention
Number of subjects: 600
Study 35621217 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 600
Study 33662047 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding for >6 months
Number of subjects: 202
Study 33662047 — intervention group
Group type: COMPARATOR
Intervention: No exclusive breastfeeding
Number of subjects: 202
Study 33026421 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age (age ≥60 years)
Number of subjects: 40438
Study 33026421 — intervention group
Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 40438
Study 33026421 — intervention group
Group type: EXPERIMENTAL
Intervention: Fair skin (vs olive, dark, or black skin)
Number of subjects: 40438
Study 33026421 — intervention group
Group type: EXPERIMENTAL
Intervention: Inability to tan (vs ability to tan deeply)
Number of subjects: 40438
Study 33026421 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous excisions of keratinocyte cancers (ever had an excision vs never had an excision)
Number of subjects: 40438
Study 33026421 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smoking (vs never smoking)
Number of subjects: 40438
Study 33026421 — intervention group
Group type: EXPERIMENTAL
Intervention: High alcohol use (≥14 alcoholic drinks per week vs no alcoholic drinks per week)
Number of subjects: 40438
Study 35218519 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 48
Study 35218519 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 48
Study 32279612 — intervention group
Group type: EXPERIMENTAL
Intervention: Harikrishna Periwound Skin Classification (HPSC) after two months of clinical attachment
Number of subjects: 30
Study 32279612 — intervention group
Group type: COMPARATOR
Intervention: Harikrishna Periwound Skin Classification (HPSC) at zero months (before attachment)
Number of subjects: 30
Study 35607304 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (added to control group treatment)
Number of subjects: 580
Study 35607304 — intervention group
Group type: COMPARATOR
Intervention: Control group (subarachnoid block or combined lumbar epidural anesthesia with bupivacaine or bupivacaine and fentanyl)
Number of subjects: 580
Study 32506579 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention A
Number of subjects: 47
Study 32506579 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention B
Number of subjects: 47
Study 32506579 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 47
Study 32909826 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertion‐preserved hamstring tendon autografts (IP‐HT)
Number of subjects: 45
Study 32909826 — intervention group
Group type: COMPARATOR
Intervention: Free hamstring tendon autografts (FHT)
Number of subjects: 45
Study 34014975 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-medication practice
Number of subjects: 250
Study 34014975 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-medication for morning sickness
Number of subjects: 250
Study 34014975 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-medication for headache
Number of subjects: 250
Study 34014975 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-medication for upper respiratory tract infections
Number of subjects: 250
Study 34014975 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasons for self-medication
Number of subjects: 250
Study 34014975 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of health insurance
Number of subjects: 250
Study 34014975 — intervention group
Group type: EXPERIMENTAL
Intervention: First trimester of pregnancy
Number of subjects: 250
Study 32836055 — intervention group
Group type: EXPERIMENTAL
Intervention: Droplet digital PCR (ddPCR) for detecting BRAF V600E mutations
Number of subjects: 35
Study 32836055 — intervention group
Group type: EXPERIMENTAL
Intervention: Droplet digital PCR (ddPCR)
Number of subjects: 35
Study 35565715 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperhomocysteinemia defined as levels ≥ 15 µmol/L
Number of subjects: 206
Study 35565715 — intervention group
Group type: EXPERIMENTAL
Intervention: Boys (mean homocysteine levels 14.1 µmol/L)
Number of subjects: 206
Study 35565715 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum levels of vitamin B12
Number of subjects: 206
Study 35565715 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum levels of folate
Number of subjects: 206
Study 34453097 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfavourable adiposity (82 SNPs)
Number of subjects: 321472
Study 34453097 — intervention group
Group type: EXPERIMENTAL
Intervention: Favourable adiposity (24 SNPs)
Number of subjects: 321472
Study 34453097 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral adiposity (25 SNPs)
Number of subjects: 321472
Study 35235092 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD (300 mg; oral)
Number of subjects: 9
Study 35235092 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 32299734 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl and midazolam (0.1 mg fentanyl and 5 mg midazolam)
Number of subjects: 170
Study 32299734 — intervention group
Group type: COMPARATOR
Intervention: Pethidine and diazepam (25 mg pethidine and 5 mg diazepam)
Number of subjects: 170
Study 616168805 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate frequency ultrasound combined with opioid analgesic (morphine)
Number of subjects: 162
Study 616168805 — intervention group
Group type: COMPARATOR
Intervention: Opioid analgesic (morphine) alone
Number of subjects: 162
Study 33629956 — intervention group
Group type: EXPERIMENTAL
Intervention: myAID (web-based decision aid)
Number of subjects: 11
Study 33629956 — intervention group
Group type: COMPARATOR
Intervention: usual care
Number of subjects: 11
Study 32456672 — intervention group
Group type: EXPERIMENTAL
Intervention: Stakeholder interviews
Number of subjects: 84
Study 32456672 — intervention group
Group type: EXPERIMENTAL
Intervention: Literature review
Number of subjects: 84
Study 32456672 — intervention group
Group type: EXPERIMENTAL
Intervention: Stakeholder input
Number of subjects: 84
Study 36196975 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-only (n = 23)
Number of subjects: 43
Study 36196975 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-visual (n = 20)
Number of subjects: 43
Study 36196975 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 43
Study 33580606 — intervention group
Group type: EXPERIMENTAL
Intervention: Laughter yoga
Number of subjects: 75
Study 32407272 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 20 mg (Maxolon 10 mg, GlaxoSmithKline, Pakistan) administered after rifampicin treatment
Number of subjects: 12
Study 32407272 — intervention group
Group type: COMPARATOR
Intervention: Rifampicin 600 mg once daily for 6 days
Number of subjects: 12
Study 36156678 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline iron deficiency
Number of subjects: 2141
Study 36156678 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline iron deficiency among participants without anemia
Number of subjects: 2141
Study 34140203 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus anterior plane block and transversus thoracis plane block
Number of subjects: 22
Study 34140203 — intervention group
Group type: COMPARATOR
Intervention: Surgical infiltration of local anesthetics
Number of subjects: 22
Study 32789625 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of PrEP
Number of subjects: 0